|
Delayed
Australian S.E.
01:10:16 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 0.7500 AUD | -6.25% |
|
-11.24% | +108.33% |
| 09-21 | Starpharma Holdings Limited(ASX:SPL) added to S&P/ASX Emerging Companies Index | CI |
| 09-20 | Starpharma Holdings Limited(ASX:SPL) added to S&P/ASX All Ordinaries Index | CI |
| Market Cap | 360M 251M 224M 208M 189M 354M 23.83B 2.49B 978M 12.46B 942M 922M 39.81B | P/E 2027 * |
-25x | P/E 2028 * | 167x |
|---|---|---|---|---|---|
| Enterprise Value | 333M 232M 207M 192M 174M 327M 22.03B 2.3B 904M 11.51B 871M 852M 36.79B | EV / Sales 2027 * |
52.8x | EV / Sales 2028 * | 12.2x |
| Free-Float |
69.55% | Yield 2027 * |
-
| Yield 2028 * | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| SPL | Delayed | |
Börse Stuttgart
| PQ6 | Delayed | |
|
OTC Markets
| SPHRF | Delayed | |
|
Deutsche Boerse AG
| PQ6 | Delayed | |
|
Berne S.E.
| PQ6 | End-of-day quote |
| 1 day | -6.25% | ||
| 1 week | -11.24% | ||
| Current month | -13.79% | ||
| 1 month | -6.25% | ||
| 3 months | +5.63% | ||
| 6 months | +7.91% | ||
| Current year | +108.33% |
| 1 week | 0.73 |  | 0.85 |
| 1 month | 0.73 | | 0.88 |
| Current year | 0.33 | | 0.88 |
| 1 year | 0.26 | | 0.88 |
| 3 years | 0.08 | | 0.88 |
| 5 years | 0.08 | | 1.38 |
| 10 years | 0.08 | | 2.52 |
| Manager | Title | Age | Since |
|---|---|---|---|
Cheryl Maley
CEO | Chief Executive Officer | - | 2024-01-07 |
Justin Cahill
DFI | Director of Finance/CFO | - | 2023-04-02 |
Miranda Sowden
HRO | Human Resources Officer | - | 2022-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Thomas
CHM | Chairman | 81 | 2014-06-12 |
David McIntyre
BRD | Director/Board Member | 55 | 2020-02-29 |
Lynda Cheng
BRD | Director/Board Member | - | 2021-07-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Expiration | Chief Executive Officer | -702,768 | 0.1473% | ||
| 8/11/26 | Buy | Chairman | 350,001 | 0.0734% | ||
| 8/11/26 | Buy | Director | 22,741 | 0.0048% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -6.25% | -11.24% | +188.46% | +476.92% | 250M | |
| -1.33% | +5.18% | +54.50% | +104.26% | 1,120B | |
| -0.69% | -2.93% | +31.35% | +66.17% | 616B | |
| -0.96% | +2.25% | +23.13% | +89.36% | 504B | |
| +0.24% | +6.23% | +33.98% | +52.38% | 367B | |
| -1.59% | -1.35% | +69.39% | +40.83% | 360B | |
| -0.40% | +4.28% | +19.17% | +42.51% | 288B | |
| -0.37% | +3.35% | -1.26% | +16.85% | 258B | |
| -1.75% | +2.43% | +42.21% | +49.85% | 234B | |
| -2.00% | +1.26% | +24.64% | +92.13% | 194B | |
| Average | -1.28% | +1.96% | +48.56% | +103.13% | 394.12B | |
| Weighted average by Cap. | -0.73% | +3.52% | +37.90% | +71.75% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 6.3M 4.4M 3.92M 3.63M 3.3M 6.2M 417M 43.56M 17.11M 218M 16.49M 16.14M 697M | 26.24M 18.31M 16.33M 15.14M 13.75M 25.83M 1.74B 181M 71.28M 908M 68.7M 67.25M 2.9B |
| Net income | -16.25M -11.34M -10.11M -9.38M -8.52M -16M -1.08B -112M -44.16M -563M -42.56M -41.66M -1.8B | 1.71M 1.19M 1.06M 985K 895K 1.68M 113M 11.81M 4.64M 59.1M 4.47M 4.38M 189M |
| Net Debt | -27.25M -19.02M -16.96M -15.72M -14.28M -26.83M -1.81B -189M -74.05M -943M -71.37M -69.86M -3.02B | -38.53M -26.89M -23.98M -22.23M -20.19M -37.93M -2.55B -267M -105M -1.33B -101M -98.77M -4.26B |
Employees
50
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | A$0.7500 | -6.25% | 2,420,375 |
| 26-10-14 | A$0.8000 | -3.61% | 1,148,946 |
| 26-10-13 | A$0.8300 | -2.35% | 2,209,167 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7500AUD
Average target price
1.220AUD
Spread / Average Target
+62.67%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
